Concepedia
Statistics
Publications
65
Citations
2.6K
H-Index
27
Active since
2008
Affiliations
Institute of Hematology & Blood Diseases Hospital(Current)
Chinese Academy of Medical Sciences & Peking Union Medical College
Tianjin Medical University Cancer Institute and Hospital
Henan Cancer Hospital
Dana-Farber Cancer Institute
Dehui Zou is an author at Institute of Hematology & Blood Diseases Hospital specializing in medicine, oncology, and hematology.
Publications per year
2008–2024
Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
Yuqin Song, Keshu Zhou, Dehui Zou et al. · Clinical Cancer Research · 2020 · 183 citations
Medicine, Oncology, Pharmacology +17
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
Yuqin Song, Keshu Zhou, Dehui Zou et al. · Blood · 2022 · 169 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study
Yuqin Song, Quanli Gao, Huilai Zhang et al. · Leukemia · 2019 · 157 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
Runxia Gu, Fang Liu, Dehui Zou et al. · Journal of Hematology & Oncology · 2020 · 112 citations · Full text
Life Sciences, Immunology, Oncology +17
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
Lihui Shi, Xiaoqi Qin, Huijun Wang et al. · Oncotarget · 2016 · 108 citations · Full text
Medicine, Hematology, Oncology +15
1–5 of 65